Market Place
Sourcing Support
Ribobay Pharma to start production of cGMP-level oligonucleotide
18 Sep 2024 //
CRTMAGAZINE
Oligonucleotides: EMA drafts new guideline on manufacturing and development
23 Jul 2024 //
RAPS
Aurorium Launches Haelium™ Pharmaceutical Solutions
25 Jun 2024 //
BUSINESSWIRE
Avidity Biosciences Closes Upsized Public Offering Of Common Stock
17 Jun 2024 //
PR NEWSWIRE
Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate
12 Jun 2024 //
PR NEWSWIRE
PepGen Announces Executive Team Promotions
11 Jun 2024 //
BUSINESSWIRE
GSK acquires oligonucleotide drug startup Elsie
07 Jun 2024 //
BIOPHARMADIVE
Asahi Kasei & Axolabs partner to accelerate oligonucleotide therapeutics dvp
11 Apr 2024 //
INDINPHARMAPOST
Elena Zakharova Wins Cancer Drug Discovery Research Award
15 Nov 2023 //
PRESS RELEASE
Intellegens, CPI Awarded Innovate UK Grant for Oligonucleotide Therapeutics
30 Aug 2023 //
CONTRACT PHARMA
EUROAPI to acquire BianoGMP to strengthen its CDMO expertise in the high-growth oligonucleotide market
30 Aug 2023 //
PRESS RELEASE
Alloy Launches Proprietary AntiClastic™ Antisense Oligonucleotide Platform
28 Jun 2023 //
BUSINESSWIRE
FDA blocks PepGen`s attempt to get 2nd oligonucleotide to clinic
31 May 2023 //
FIERCE BIOTECH
PepGen tumbles after FDA hold notice on myotonic dystrophy study
31 May 2023 //
BIOSPACE
Purification – A Bottleneck For Large-Scale Manufacturing Oligonucleotide API
12 May 2023 //
PRESS RELEASE
Avidity Receives FDA Orphan Drug Designation for AOC 1020 to treat FSHD
15 Feb 2023 //
PR NEWSWIRE
New mass spectrometry (MS) characterization for an accurate identification of oligonucleotide impurities
20 Jan 2023 //
PRESS RELEASE
BioSpring invests €100M+ into new oligonucleotide API facilities in Germany
22 Dec 2022 //
ENDPTS
SpliSense begins Phase I/II trial of SPL84 for cystic fibrosis
15 Dec 2022 //
CLINICALTRIALSARENA
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
14 Dec 2022 //
BIOSPACE
Vienna Tides EURO 2022 meet for Phosphoramidite for oligonucleotides
18 Nov 2022 //
PRESS RELEASE
Oligonucleotide therapy helps to prevent chronic hepatitis B
09 Nov 2022 //
EUROPEANPHARMACEUTICALREVIEW
Bachem Innovates its Manufacturing Capabilities
14 Oct 2022 //
CHEMANAGER
Our Key Ingredients For A Successful Oligonucleotide Drug Development
06 Oct 2022 //
PRESS RELEASE
Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide
01 Oct 2022 //
PHARMABIZ
Regulus Announces Positive Safety and PK Data from the PI SAD Trial of RGLS8429
12 Sep 2022 //
PRNEWSWIRE
Stoke Therapeutics Reports Second Quarter Financial Results
08 Aug 2022 //
BUSINESS WIRE
Innovation Transforming Oligonucleotide Manufacturing
11 May 2022 //
PRESS RELEASE
ST Pharm to Expand Oligonucleotide Facility
30 Nov 2021 //
CONTRACTPHARMA
Ionis pays $45M to expand oligonucleotide delivery toolkit
14 Jul 2021 //
FIERCEBIOTECH
Asymchem Expands Oligonucleotides Mfg. Capacity
26 Mar 2021 //
CONTRACTPHARMA
OliX to Present New Data in Liver and Ophthalmic Areas at 16th Meeting (OTS)
29 Sep 2020 //
GLOBENEWSWIRE
Innovate UK funding for new precision cancer treatment technology
24 Sep 2020 //
PHARMAPHORUM
Aligos Doses First in Ph1 Proof of Concept Study of OligonucleotideALG-010133
18 Aug 2020 //
GLOBENEWSWIRE
RIBOMIC Announces First Injection in the Phase 2 Clinical Trial of RBM-007
19 Feb 2020 //
BUSINESSWIRE
WuXi STA opens oligonucleotide large-scale manufacturing facility
03 Jan 2020 //
BIOSPECTRUMASIA
CordenPharma Announces Commercial Oligonucleotide API Manufacturing Expansion in CordenPharma Colorado
02 May 2018 //
PRESS RELEASE
Wave Life Sciences to Present Data on ALS and FTD Programs
17 Apr 2018 //
PRESS RELEASE
Wave Life Sciences, Deep Genomics Enter Collaboration
10 Apr 2018 //
CONTRACTPHARMA
Avecia Announces Opening of Cambridge, MA Office
01 Feb 2018 //
PR NEWSWIRE
CordenPharma & GE Healthcare Offer Unique End-to-End Solution to Accelerate Oligonucleotide Drug Development
28 Jun 2017 //
PRESS RELEASE
Agilent will double oligonucleotide capacity with a new Colorado plant
13 Aug 2016 //
FIERCE PHARMA
Agilent to up Oligo API capacity with new manufacturing plant
11 Aug 2016 //
IN PHARMATECHNOLOGIST
